Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resistance, APC”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT02833194
What this trial is testing

Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeFactor V Leiden Thrombophilia
Centre Hospitalier Universitaire de Nīmes 1,592
Not applicableStudy completedNCT05051826
What this trial is testing

Effect of Resistance Training in Water Combined With Land on Starting and Turning ,12-weeks Resistance Training

Who this might be right for
Resistance, APC
Universiti Putra Malaysia 80
Large-scale testing (Phase 3)Active Not RecruitingNCT03806426
What this trial is testing

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

Who this might be right for
Familial Adenomatous Polyposis
S.L.A. Pharma AG 204
Testing effectiveness (Phase 2)Looking for participantsNCT05919264
What this trial is testing

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerColorectal CancerSolid Tumor+17 more
Parabilis Medicines, Inc. 575
Not applicableUnknownNCT06182501
What this trial is testing

Interference by Activated Protein C Resistance in the Determination of Protein S Activity

Who this might be right for
Resistance to Activated Protein C in the Determination of Protein S Activity
University Hospital, Strasbourg, France 9,470
Testing effectiveness (Phase 2)Ended earlyNCT02982694
What this trial is testing

Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer

Who this might be right for
MSIColoRectal CancerChemotherapy+1 more
Vall d'Hebron Institute of Oncology 46